We came across a bullish thesis on Genmab A/S (GMAB) on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on GMAB. Genmab A/S (GMAB)’s share was trading at $20.20 as of March 18th. GMAB’s trailing and forward P/E were 11.41 and 11.61 respectively according to Yahoo Finance.
A medical professional in a hospital, using targeted cancer therapuetics to treat cancer patients.
Genmab (GMAB) is a leading biotech company based in Copenhagen, specializing in...
